Drug · DIN 02546833
ZOLMITRIPTAN
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since March 28, 2024.
- Drug Identification Number (DIN)
- 02546833
- Company (DIN owner)
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Zolmitriptan N02CC03
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ZOLMITRIPTAN | 2.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 28, 2024: NOC 32979Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement Between Two Manufacturers
Other DINs named ZOLMITRIPTAN
- DIN 02379929 · Cancelled Post Market
- DIN 02418924 · Approved
- DIN 02442655 · Dormant